These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25773045)

  • 1. RyR2 Common Gene Variant G1886S and the Risk of Ventricular Arrhythmias in ICD Patients with Heart Failure.
    Francia P; Adduci C; Semprini L; Stanzione R; Serdoz A; Caprinozzi M; Santini D; Cotugno M; Palano F; Musumeci MB; Rubattu S; Volpe M
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):656-61. PubMed ID: 25773045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common genetic variants in selected Ca²⁺ signaling genes and the risk of appropriate ICD interventions in patients with heart failure.
    Francia P; Adduci C; Ricotta A; Stanzione R; Sensini I; Uccellini A; Frattari A; Balla C; Cotugno M; Cappato R; Rubattu S; Volpe M
    J Interv Card Electrophysiol; 2013 Dec; 38(3):169-77. PubMed ID: 24048583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common RyR2 variants associate with ventricular arrhythmias and sudden cardiac death in chronic heart failure.
    Ran Y; Chen J; Li N; Zhang W; Feng L; Wang R; Hui R; Zhang S; Pu J
    Clin Sci (Lond); 2010 Jun; 119(5):215-23. PubMed ID: 20408814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
    J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy.
    Sesselberg HW; Moss AJ; McNitt S; Zareba W; Daubert JP; Andrews ML; Hall WJ; McClinitic B; Huang DT;
    Heart Rhythm; 2007 Nov; 4(11):1395-402. PubMed ID: 17954398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ryanodine receptor 2 inhibition reduces dispersion of cardiac repolarization, improves contractile function, and prevents sudden arrhythmic death in failing hearts.
    Joshi P; Estes S; DeMazumder D; Knollmann BC; Dey S
    Elife; 2023 Dec; 12():. PubMed ID: 38078905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of spironolactone on ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators.
    Zarraga IG; Dougherty CM; MacMurdy KS; Raitt MH
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):739-47. PubMed ID: 22773022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators.
    Blaschke F; Knaus T; Celebi O; Krebs A; Nitardy A; Habedank D; Dietz R; Stockburger M
    Europace; 2012 Feb; 14(2):224-9. PubMed ID: 21946820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the GNAS Gene as Predictors of Ventricular Tachyarrhythmias and Sudden Cardiac Death: Results From the DISCOVERY Trial and Oregon Sudden Unexpected Death Study.
    Wieneke H; Svendsen JH; Lande J; Spencker S; Martinez JG; Strohmer B; Toivonen L; Le Marec H; Garcia-Fernandez FJ; Corrado D; Huertas-Vazquez A; Uy-Evanado A; Rusinaru C; Reinier K; Foldesi C; Hulak W; Chugh SS; Siffert W
    J Am Heart Assoc; 2016 Nov; 5(12):. PubMed ID: 27895044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of obesity on the effectiveness of cardiac resynchronization to reduce the risk of first and recurrent ventricular tachyarrhythmia events.
    Szepietowska B; Polonsky B; Sherazi S; Biton Y; Kutyifa V; McNitt S; Aktas M; Moss AJ; Zareba W
    Cardiovasc Diabetol; 2016 Jul; 15():93. PubMed ID: 27388610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
    Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D
    Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of ventricular tachyarrhythmias in patients treated with CRT-D.
    Kutyifa V; Klein HU; Wang PJ; McNitt S; Polonsky B; Zima E; Merkely B; Moss AJ; Zareba W
    Heart Rhythm; 2013 Jul; 10(7):943-50. PubMed ID: 23639624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clustering of ventricular tachyarrhythmias in heart failure patients implanted with a biventricular cardioverter defibrillator.
    Lunati M; Gasparini M; Bocchiardo M; Curnis A; Landolina M; Carboni A; Luzzi G; Zanotto G; Ravazzi P; Magenta G; Denaro A; Distefano P; Grammatico A;
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1299-306. PubMed ID: 17239095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.
    Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC
    Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of the fibrillation number in patients with an implantable cardioverter defibrillator.
    Hwang M; Lee H; Lee YS; Chung S; Choi SH; Shim EB; Pak HN
    Prog Biophys Mol Biol; 2014 Sep; 116(1):33-9. PubMed ID: 25236363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.